Asan Medical Center Reaches 2,000th Head and Neck Cancer Reconstruction Milestone
When a 50-year-old patient named Song was diagnosed with oral cancer, he underwent surgery to remove his entire tongue.
Search results for "tumor"
Silent Killers in the Brain: Why Cerebral Aneurysms Go Unnoticed Until They Rupture
Most illnesses announce themselves through distinct warning signs, but cerebral aneurysms are different. Until they rupture, these dangerous bulges...
South Korea’s First Homegrown CAR-T, Rimqarto, Moves Closer to Coverage with 67% Complete Response Rate
Curocell announced on Sept. 4 that its chimeric antigen receptor T-cell (CAR-T) therapy Rimqarto (generic name:...
Keimyung University Dongsan Hospital Reaches 10,000 Robotic Surgeries, First Center Outside Seoul Area to Hit Milestone
Amid the ongoing concentration of patients traveling to major hospitals in the Seoul metropolitan area for specialized...
Hansol Hospital Reaches 200 Single-Port Robotic Surgeries in 8 Months
Hansol Hospital, a colorectal specialty hospital designated by the Ministry of Health and Welfare, announced Sept.
Can Daraxonrasib Reshape Pancreatic Cancer Care? Experts Weigh Promise and Limits
Pancreatic cancer remains one of the most formidable malignancies. Because early-stage disease rarely produces distinct...
Hanyang University Hospital Launches Dedicated Cancer Hospital, Aiming for One-Week Diagnosis-to-Surgery Window
Hanyang University Hospital is reorganizing the cancer center it has operated for 35 years into Hanyang University...
Severe Lung Complications Drop Below 10% for Early Lung Cancer Patients with IPF Treated with Proton Therapy
For patients diagnosed with idiopathic pulmonary fibrosis —a chronic disease in which lung tissue inexplicably becomes...
Deciphering Ampullary Cancer: Korean Researchers Identify Aggressive Subtype of Rare Disease
Where the bile duct and pancreatic duct meet to drain digestive juices into the duodenum, a rare and elusive malignancy...
Samyang Biopharm’s NanoReady Delivers 20x mRNA Payload for Personalized Cancer Vaccines
Samyang Biopharm announced on the 20th that nonclinical study results for its proprietary gene delivery platform,...